RAC 6.45% $1.65 race oncology ltd

Ann: Zantrene Improves Immune Therapy Treatment of Melanoma, page-24

  1. 2,335 Posts.
    lightbulb Created with Sketch. 448
    Unbelievable gigantic if this also works with melanoma or other cancers in humans, Zantrene will be used as a standard  therapy for cancer by  then, time will tell but many in healthcare and patients will be euphoric with this outcome already

    Used at low concentrations, Zantrene was found to enhance cancer immunotherapy in three distinct and complementary ways: (1) direct killing of melanoma cells; (2) activation of immune cells targeting the tumour, and (3) reducing the expression of immune evasion genes in the tumour.

    Just nagnificent !!!
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.65
Change
0.100(6.45%)
Mkt cap ! $274.5M
Open High Low Value Volume
$1.65 $1.75 $1.61 $687.0K 410.0K

Buyers (Bids)

No. Vol. Price($)
1 3047 $1.65
 

Sellers (Offers)

Price($) Vol. No.
$1.70 18354 2
View Market Depth
Last trade - 16.10pm 14/05/2024 (20 minute delay) ?
Last
$1.67
  Change
0.100 ( 8.61 %)
Open High Low Volume
$1.64 $1.73 $1.63 33428
Last updated 15.54pm 14/05/2024 ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.